Clinical Trials
462 trialsPASSAT
AstraZeneca
OSIREAL
AstraZeneca
MK-3475-U01
Merck Sharp & Dohme LLC
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Hoffmann-La Roche
CREATE
AstraZeneca
RACE-2L
AstraZeneca
NAUTIC
AstraZeneca
LUNG-ROLL
AstraZeneca
CHOICE
AstraZeneca
A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC
Pfizer
DESCENT-1
A2 Biotherapeutics Inc.
A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
Ono Pharmaceutical Co., Ltd.
Pan HER2
AstraZeneca
Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
Bristol-Myers Squibb
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Pfizer
FOREFRONT
AstraZeneca
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
AstraZeneca
MYLUNG
US Oncology Research
MYLUNG
US Oncology Research
ECHO
AstraZeneca
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
SECURE
AstraZeneca
CEMI-LUNG
Regeneron Pharmaceuticals
DeniLA
AstraZeneca
A Study in Non-Small Cell Lung Cancer
N-Power Medicine
MAP
AstraZeneca
A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment
Pfizer
DREAM
AstraZeneca
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
Regeneron Pharmaceuticals
LEPIDOPTERA
Janssen Research & Development, LLC
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Hoffmann-La Roche
LOOP
AstraZeneca
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
SHIELD
Guardant Health, Inc.
CYBRID-01
Elephas
ELEPHAS-02
Elephas
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
AB1MALTISC-UK
Creo Medical Limited
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
AstraZeneca
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
TraveraRTGx
Travera Inc
ENTIRETY
Takeda
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
Hoffmann-La Roche
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Everest Detection, Inc.
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Amgen
LARCS
Intuitive Surgical
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Tempus AI